We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.27%
2 Consumer Discretionary 9.91%
3 Healthcare 7.11%
4 Financials 6.94%
5 Communication Services 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHAS
4326
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$244K ﹤0.01%
78,547
+60,873
+344% +$203K
HGV icon
4327
CALL
Hilton Grand Vacations
HGV
$3.84B
$243K ﹤0.01%
5,100
PANL icon
4328
Pangaea Logistics
PANL
$501M
$243K ﹤0.01%
+48,106
New +$236K
PRI icon
4329
Primerica
PRI
$9.81B
$242K ﹤0.01%
1,574
-100
-6% -$14.9K
FOXA icon
4330
PUT
Fox Class A
FOXA
$23.2B
$241K ﹤0.01%
+6,000
New +$221K
POWL icon
4331
Powell Industries
POWL
$8.46B
$241K ﹤0.01%
+29,463
New +$265K
EFX icon
4332
Equifax
EFX
$20.3B
$240K ﹤0.01%
948
-116,792
-99% -$30.4M
PRGO icon
4333
Perrigo
PRGO
$1.4B
$239K ﹤0.01%
5,053
-261,640
-98% -$11.6M
ZYME icon
4334
Zymeworks
ZYME
$1.68B
$239K ﹤0.01%
8,247
-537
-6% -$17.9K
ROSS.WS
4335
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$239K ﹤0.01%
268,888
+224,444
+505% +$205K
AVGO icon
4336
Broadcom
AVGO
$1.82T
$238K ﹤0.01%
4,910
-1,200
-20% -$58.4K
YUMC icon
4337
Yum China
YUMC
$14.9B
$238K ﹤0.01%
4,097
-7,398
-64% -$455K
RAIN
4338
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$238K ﹤0.01%
15,923
-11,799
-43% -$201K
COHR icon
4339
PUT
Coherent
COHR
$55.2B
$237K ﹤0.01%
4,000
RSI icon
4340
Rush Street Interactive
RSI
$3.24B
$236K ﹤0.01%
12,302
-38,944
-76% -$533K
IOVA icon
4341
Iovance Biotherapeutics
IOVA
$2.23B
$235K ﹤0.01%
9,514
-16,072
-63% -$379K
KIDS icon
4342
OrthoPediatrics
KIDS
$485M
$235K ﹤0.01%
+3,589
New +$233K
LBTYA icon
4343
Liberty Global Class A
LBTYA
$3.31B
$235K ﹤0.01%
7,886
-9,195
-54% -$255K
BFX
4344
PUT
DELISTED
BowFlex Inc.
BFX
$233K ﹤0.01%
+25,000
New +$321K
BOKF icon
4345
BOK Financial
BOKF
$8.64B
$232K ﹤0.01%
2,590
-15,809
-86% -$1.35M
CLW icon
4346
Clearwater Paper
CLW
$271M
$232K ﹤0.01%
6,057
-28,581
-83% -$909K
AGYS icon
4347
Agilysys
AGYS
$2.78B
$231K ﹤0.01%
4,414
-871
-16% -$47.6K
BLSA
4348
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$231K ﹤0.01%
+23,127
New +$233K
CKPT
4349
DELISTED
Checkpoint Therapeutics
CKPT
$230K ﹤0.01%
6,963
-2,112
-23% -$62.4K
GNPX icon
4350
Genprex
GNPX
$3.94M
$230K ﹤0.01%
2
+1
+100% +$129K

Similar funds

D.E. Shaw & Co's Q3 2021 Portfolio in Review

As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.

  • D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.